# K200206: AXS Vecta 71 Intermediate Catheter, AXS Vecta 74 Intermediate Catheter

- Pathway: 510(k) (Special)
- Applicant: Stryker Neurovascular
- Decided: Feb 27, 2020 after 30 days
- Product code: QJP (Catheter, Percutaneous, Neurovasculature)
- Device class: 2
- Regulation: 21 CFR 870.1250
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 9 generations back to K003880 (2001). 14 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 16 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K190833: AXS Vecta Aspiration Catheter, Stryker Neurovascular (2019) Summary page 5.

## Most influential descendants
- K241768: Broadway 8 Catheter (2024), 0 descendants of its own

## Indications for use
The AXS Vecta Intermediate Catheter is indicated for use in facilitating the insertion and guidance of appropriately sized interventional devices into a selected blood vessel in the peripheral and neurovascular systems. The AXS Vecta Intermediate Catheter is also indicated for use as a conduit for retrieval devices.

Source page: https://510kreport.com/device/K200206
Methodology: https://510kreport.com/methodology